|
|
|
|
|
|
|
|
|
|
"Thus, these candidate biomarkers should continue to be actively explored in trials of antiangiogenic agents in patients, to get closer to the goal of improving and individualizing cancer therapy."
Thursday, January 07, 2010
JCO Editorial: Biomarkers of Antiangiogenic Therapy: How Do We Move From Candidate Biomarkers to Valid Biomarkers?
"Thus, these candidate biomarkers should continue to be actively explored in trials of antiangiogenic agents in patients, to get closer to the goal of improving and individualizing cancer therapy."
Subscribe to:
Post Comments
(
Atom
)
AngioRx: Valid Biomarker of Antiangiogenic Therapy
ReplyDeletehttp://cancerfocus.org/forum/showthread.php?t=3372